Mike Bybel

Comparative Trial of the Safety and Immunogenicity of Quadrivalent (A, C, Y, W-135) Meningococcal Polysaccharide-Diphtheria Conjugate Vaccine Versus Quadrivalent Polysaccharide Vaccine in Two- to Ten-Year-Old Children

Michael E. Pichichero, Janet R. Casey, Mark M. Blatter et al. · The Pediatric Infectious Disease Journal · 2005 · 120 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger

G Campagne, Amadou Garba, Pascal Fabre et al. · The Pediatric Infectious Disease Journal · 2000 · 104 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Immunogenicity, safety, and memory of different schedules of Neisseria meningitidis A/C-diphtheria toxoid conjugate vaccine in infants in Niger

Jean‐Philippe Chippaux, Amadou Garba, C. Ethevenaux et al. · Vaccine · 2004 · 28 citations

Veterinary Medicine, Immunology, Infectious Diseases +14

Choosing a Route of Administration for Quadrivalent Meningococcal Polysaccharide Vaccine: Intramuscular versus Subcutaneous

Frederick L. Ruben, James E. Froeschle, Carlton Meschievitz et al. · Clinical Infectious Diseases · 2001 · 26 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Assignment of<i>Neisseria meningitidis</i>Serogroups A, C, W135, and Y Anticapsular Total Immunoglobulin G (IgG), IgG1, and IgG2 Concentrations to Reference Sera

Helen Joseph, Paul Balmer, Mike Bybel et al. · Clinical and Vaccine Immunology · 2004 · 24 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13